Ethadione
Anticonvulsant medication
Ethadione is a medication used primarily as an anticonvulsant in the treatment of epilepsy. It belongs to the class of drugs known as oxazolidinediones, which are used to manage seizures.
Chemical Structure and Properties[edit]

Ethadione is chemically classified as an oxazolidinedione. Its chemical formula is C9H10N2O3. The structure of Ethadione includes a five-membered ring containing nitrogen and oxygen atoms, which is characteristic of the oxazolidinedione class.
Mechanism of Action[edit]
Ethadione works by stabilizing the neuronal membranes and reducing the repetitive firing of neurons. This action helps to prevent the spread of seizure activity in the brain. The exact mechanism by which Ethadione exerts its anticonvulsant effects is not fully understood, but it is believed to involve the modulation of ion channels and neurotransmitter release.
Uses[edit]
Ethadione is used in the management of certain types of seizures, particularly in patients who do not respond well to other anticonvulsant medications. It is not typically a first-line treatment but may be used in specific cases where other medications are ineffective or not tolerated.
Side Effects[edit]
The use of Ethadione can be associated with several side effects. Common side effects include drowsiness, dizziness, and nausea. More serious side effects can include allergic reactions, blood disorders, and liver toxicity. Patients taking Ethadione require regular monitoring to manage these potential adverse effects.
Pharmacokinetics[edit]
Ethadione is absorbed from the gastrointestinal tract and metabolized in the liver. It is excreted primarily through the kidneys. The pharmacokinetic profile of Ethadione necessitates careful dosing to maintain therapeutic levels while minimizing toxicity.
History[edit]
Ethadione was developed in the mid-20th century as part of the search for effective anticonvulsant medications. It was one of several oxazolidinediones introduced during this period, although its use has declined with the development of newer anticonvulsants with improved safety profiles.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian